Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

BRIDGEBIO PHARMA, INC.

Filed by BRIDGEBIO PHARMA, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-02 06:26:10 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
Not reported
Expenses
$510,000.00
Filing UUID
e00c3f02-7263-4939-9fc0-057fb57295ad
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act Priority for Pediatric Cures Act (H.R.10359)

Literal federal measure citations: H.R.1532, S.822, H.R.10359

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.